|
2026-05-20 |
2026-05-19 |
S
Sale
|
Director of Issuer
Non-Executive Director
|
45,654
-48.3%
363.16
US$1,491,238
|
45,654
-48.3%
|
363.16
|
US$1,491,238
|
|
|
2026-05-20 |
2026-05-19 |
PlS
Planned sale
|
Non-Executive Director
|
70,968
-26.7%
459.91
US$2,236,645
|
70,968
-26.7%
|
459.91
|
US$2,236,645
|
|
|
2026-05-19 |
2026-05-19 |
PrS
Proposed sale
|
Director
Non-Executive Director
|
42,624
397.21
US$1,166,730
|
42,624
|
397.21
|
US$1,166,730
|
|
|
2026-05-01 |
2026-04-30 |
S
Sale
|
Senior Officer of Issuer
Officer
|
20,000
-6.6%
6.00
US$120,000
|
20,000
-6.6%
|
6.00
|
US$120,000
|
|
|
2026-03-04 |
2026-03-03 |
S
Sale
|
Senior Officer of Issuer
Officer
|
4,420
-1.8%
5.77
US$25,503
|
4,420
-1.8%
|
5.77
|
US$25,503
|
|
|
2026-03-03 |
2026-03-03 |
PlS
Planned sale
|
EVP, General Counsel
Officer
|
4,420
-0.7%
5.77
US$25,503
|
4,420
-0.7%
|
5.77
|
US$25,503
|
|
|
2026-03-03 |
2026-03-03 |
PrS
Proposed sale
|
Officer
Officer
|
4,420
5.77
US$25,503
|
4,420
|
5.77
|
US$25,503
|
|
|
2026-03-04 |
2026-03-02 |
S
Sale
|
Senior Officer of Issuer
Officer
|
6,856
-2.7%
5.78
US$39,628
|
6,856
-2.7%
|
5.78
|
US$39,628
|
|
|
2026-03-03 |
2026-03-02 |
PlS
Planned sale
|
EVP, General Counsel
Officer
|
6,856
-0.9%
5.78
US$39,628
|
6,856
-0.9%
|
5.78
|
US$39,628
|
|
|
2026-03-02 |
2026-03-02 |
PrS
Proposed sale
|
Officer
Officer
|
6,856
5.78
US$39,628
|
6,856
|
5.78
|
US$39,628
|
|
|
2026-03-02 |
2026-02-27 |
S
Sale
|
Senior Officer of Issuer
Officer
|
8,388
-3.7%
5.95
US$49,909
|
8,388
-3.7%
|
5.95
|
US$49,909
|
|
|
2026-02-27 |
2026-02-27 |
PlS
Planned sale
|
EVP, General Counsel
Officer
|
8,388
-1.0%
5.95
US$49,909
|
8,388
-1.0%
|
5.95
|
US$49,909
|
|
|
2026-02-27 |
2026-02-27 |
PrS
Proposed sale
|
Officer
Officer
|
8,388
5.95
US$49,909
|
8,388
|
5.95
|
US$49,909
|
|
|
2025-12-08 |
2025-12-03 |
S
Sale
|
Director or Senior Officer of Insider or Subsidiary of Issuer
Executive Director
|
11,500
7.00
US$80,500
|
11,500
|
7.00
|
US$80,500
|
|
|
2025-12-08 |
2025-12-03 |
S
Sale
|
Senior Officer of Issuer
Officer
|
21,568
7.00
US$150,976
|
21,568
|
7.00
|
US$150,976
|
|
|
2025-11-28 |
2025-11-25 |
B
Purchase
|
Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer
Executive Director
|
2,500,000
6.25
US$15,625,000
|
2,500,000
|
6.25
|
US$15,625,000
|
|
|
2025-11-28 |
2025-11-25 |
B
Purchase
|
Large shareholder
|
2,500,000
+3.5%
6.25
US$15,625,000
|
2,500,000
+3.5%
|
6.25
|
US$15,625,000
|
|
|
2025-09-08 |
2025-09-08 |
PrS
Proposed sale
|
Officer
Officer
|
13,370
7.31
US$97,735
|
13,370
|
7.31
|
US$97,735
|
|
|
2025-09-08 |
2025-09-08 |
S
Sale
|
Senior Officer of Issuer
Officer
|
13,370
-6.4%
7.31
US$97,735
|
13,370
-6.4%
|
7.31
|
US$97,735
|
|
|
2025-09-08 |
2025-09-08 |
PlS
Planned sale
|
EVP, General Counsel
Officer
|
13,370
-2.6%
7.31
US$97,735
|
13,370
-2.6%
|
7.31
|
US$97,735
|
|
|
2025-08-27 |
2025-08-21 |
S
Sale
|
Director of Issuer
Non-Executive Director
|
15,912
-45.0%
7.66
US$121,886
|
15,912
-45.0%
|
7.66
|
US$121,886
|
|
|
2025-08-22 |
2025-08-21 |
S
Sale
|
Non-Executive Director
|
15,912
-17.7%
7.66
US$121,886
|
15,912
-17.7%
|
7.66
|
US$121,886
|
|
|
2025-08-21 |
2025-08-21 |
PrS
Proposed sale
|
Director
Non-Executive Director
|
15,912
7.66
US$121,888
|
15,912
|
7.66
|
US$121,888
|
|
|
2025-08-15 |
2025-08-14 |
B
Purchase
|
Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer
Executive Director
|
34,721,118
+1070.6%
9.00
US$312,490,062
|
34,721,118
+1070.6%
|
9.00
|
US$312,490,062
|
|
|
2025-08-14 |
2025-08-14 |
B
Purchase
|
Non-Executive Director
|
34,721,118
+96.4%
9.00
US$312,490,062
|
34,721,118
+96.4%
|
9.00
|
US$312,490,062
|
|
|
2025-08-13 |
2025-08-13 |
B
Purchase
|
Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer
Executive Director
|
86,409
+2.7%
7.06
US$610,048
|
86,409
+2.7%
|
7.06
|
US$610,048
|
|
|
2025-08-13 |
2025-08-13 |
B
Purchase
|
Non-Executive Director
|
86,409
+0.2%
7.06
US$610,048
|
86,409
+0.2%
|
7.06
|
US$610,048
|
|
|
2025-08-13 |
2025-08-12 |
B
Purchase
|
Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer
Executive Director
|
1,156,640
+57.8%
6.88
US$7,957,683
|
1,156,640
+57.8%
|
6.88
|
US$7,957,683
|
|
|
2025-08-13 |
2025-08-12 |
B
Purchase
|
Non-Executive Director
|
1,156,640
+3.3%
6.88
US$7,957,683
|
1,156,640
+3.3%
|
6.88
|
US$7,957,683
|
|
|
2025-08-13 |
2025-08-11 |
B
Purchase
|
Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer
Executive Director
|
2,000,000
6.35
US$12,700,000
|
2,000,000
|
6.35
|
US$12,700,000
|
|
|
2025-08-13 |
2025-08-11 |
B
Purchase
|
Non-Executive Director
|
2,000,000
+6.1%
6.35
US$12,700,000
|
2,000,000
+6.1%
|
6.35
|
US$12,700,000
|
|
|
2025-06-17 |
2025-06-13 |
B
Purchase
|
Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer
Executive Director
|
1,782,030
+13.1%
5.94
US$10,585,258
|
1,782,030
+13.1%
|
5.94
|
US$10,585,258
|
|
|
2025-06-17 |
2025-06-13 |
B
Purchase
|
Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer
Executive Director
|
1,782,029
+28.6%
5.94
US$10,585,252
|
1,782,029
+28.6%
|
5.94
|
US$10,585,252
|
|
|
2025-06-17 |
2025-06-13 |
B
Purchase
|
Non-Executive Director
|
3,564,059
+12.2%
5.94
US$21,170,510
|
3,564,059
+12.2%
|
5.94
|
US$21,170,510
|
|
|
2025-06-16 |
2025-06-12 |
B
Purchase
|
Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer
Executive Director
|
502,688
+3.8%
5.47
US$2,749,703
|
502,688
+3.8%
|
5.47
|
US$2,749,703
|
|
|
2025-06-16 |
2025-06-12 |
B
Purchase
|
Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer
Executive Director
|
502,688
+8.8%
5.47
US$2,749,703
|
502,688
+8.8%
|
5.47
|
US$2,749,703
|
|
|
2025-06-12 |
2025-06-12 |
B
Purchase
|
Non-Executive Director
|
1,005,376
+3.6%
5.47
US$5,499,407
|
1,005,376
+3.6%
|
5.47
|
US$5,499,407
|
|
|
2025-06-16 |
2025-06-11 |
B
Purchase
|
Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer
Executive Director
|
514,549
+4.1%
5.24
US$2,696,237
|
514,549
+4.1%
|
5.24
|
US$2,696,237
|
|
|
2025-06-16 |
2025-06-11 |
B
Purchase
|
Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer
Executive Director
|
514,549
+9.9%
5.24
US$2,696,237
|
514,549
+9.9%
|
5.24
|
US$2,696,237
|
|
|
2025-06-12 |
2025-06-11 |
B
Purchase
|
Non-Executive Director
|
1,029,098
+3.8%
5.24
US$5,392,474
|
1,029,098
+3.8%
|
5.24
|
US$5,392,474
|
|
|
2025-06-14 |
2025-06-10 |
B
Purchase
|
Director of Issuer, Director or Senior Officer of Insider or Subsidiary of Issuer
Executive Director
|
754,134
5.05
US$3,808,377
|
754,134
|
5.05
|
US$3,808,377
|
|
|
2025-06-12 |
2025-06-10 |
B
Purchase
|
Non-Executive Director
|
754,134
+2.9%
5.05
US$3,808,377
|
754,134
+2.9%
|
5.05
|
US$3,808,377
|
|
|
2024-12-03 |
2024-12-02 |
PlS
Planned sale
|
EVP, General Counsel
Officer
|
440
-0.1%
8.35
US$3,674
|
440
-0.1%
|
8.35
|
US$3,674
|
|
|
2024-12-02 |
2024-12-02 |
PrS
Proposed sale
|
Officer
Officer
|
440
8.35
US$3,674
|
440
|
8.35
|
US$3,674
|
|
|
2024-09-09 |
2024-09-06 |
PlS
Planned sale
|
EVP, General Counsel
Officer
|
13,370
-3.0%
6.21
US$83,028
|
13,370
-3.0%
|
6.21
|
US$83,028
|
|
|
2024-09-09 |
2024-09-06 |
S
Sale
|
Senior Officer of Issuer
Officer
|
13,370
-10.0%
6.21
US$83,028
|
13,370
-10.0%
|
6.21
|
US$83,028
|
|
|
2024-09-06 |
2024-09-06 |
PrS
Proposed sale
|
Officer
Officer
|
13,370
6.21
US$83,028
|
13,370
|
6.21
|
US$83,028
|
|
|
2024-03-04 |
2024-03-04 |
PrS
Proposed sale
|
Officer
Officer
|
6,313
9.80
US$61,867
|
6,313
|
9.80
|
US$61,867
|
|
|
2024-03-04 |
2024-03-04 |
PlS
Planned sale
|
EVP, General Counsel
Officer
|
133
-0.0%
9.80
US$1,303
|
133
-0.0%
|
9.80
|
US$1,303
|
|
|
2024-03-04 |
2024-03-04 |
PlS
Planned sale
|
EVP, General Counsel
Officer
|
1,561
-0.3%
9.80
US$15,298
|
1,561
-0.3%
|
9.80
|
US$15,298
|
|
|
2024-03-04 |
2024-03-04 |
PlS
Planned sale
|
EVP, General Counsel
Officer
|
199
-0.0%
9.80
US$1,950
|
199
-0.0%
|
9.80
|
US$1,950
|
|
|
2024-03-04 |
2024-03-04 |
PlS
Planned sale
|
EVP, General Counsel
Officer
|
4,420
-0.9%
9.80
US$43,316
|
4,420
-0.9%
|
9.80
|
US$43,316
|
|
|
2023-12-05 |
2023-12-05 |
PrS
Proposed sale
|
Officer
Officer
|
220
7.38
US$1,624
|
220
|
7.38
|
US$1,624
|
|
|
2023-12-05 |
2023-12-05 |
PlS
Planned sale
|
EVP, General Counsel
Officer
|
220
-0.1%
7.38
US$1,624
|
220
-0.1%
|
7.38
|
US$1,624
|
|
|
2023-11-07 |
2023-11-06 |
S
Sale
|
Senior Officer of Issuer
Officer
|
43
-0.1%
7.61
US$327
|
43
-0.1%
|
7.61
|
US$327
|
|
|
2023-11-06 |
2023-11-06 |
PrS
Proposed sale
|
Officer
Officer
|
43
7.61
US$327
|
43
|
7.61
|
US$327
|
|
|
2023-11-06 |
2023-11-06 |
PlS
Planned sale
|
EVP, General Counsel
Officer
|
43
-0.0%
7.61
US$327
|
43
-0.0%
|
7.61
|
US$327
|
|
|
2023-09-06 |
2023-09-06 |
PrS
Proposed sale
|
Officer
Officer
|
6,685
8.28
US$55,352
|
6,685
|
8.28
|
US$55,352
|
|
|
2023-09-06 |
2023-09-06 |
PlS
Planned sale
|
EVP, General Counsel
Officer
|
6,685
-1.7%
8.28
US$55,352
|
6,685
-1.7%
|
8.28
|
US$55,352
|
|
|
2023-03-06 |
2023-03-06 |
PrS
Proposed sale
|
Officer
Officer
|
495
9.17
US$4,539
|
495
|
9.17
|
US$4,539
|
|
|
2023-03-01 |
2023-02-28 |
S
Sale
|
Senior Officer of Issuer
Officer
|
292
-1.3%
9.32
US$2,721
|
292
-1.3%
|
9.32
|
US$2,721
|
|
|
2023-03-01 |
2023-02-28 |
PlS
Planned sale
|
EVP, General Counsel
Officer
|
292
-0.1%
9.32
US$2,721
|
292
-0.1%
|
9.32
|
US$2,721
|
|
|
2022-04-15 |
2022-04-14 |
PlS
Planned sale
|
U.S. President-Pharma Business
Officer
|
1,595
-1.7%
22.19
US$35,393
|
1,595
-1.7%
|
22.19
|
US$35,393
|
|
|
2022-03-16 |
2022-03-15 |
PlS
Planned sale
|
U.S. President-Pharma Business
Officer
|
4,846
-5.0%
22.20
US$107,581
|
4,846
-5.0%
|
22.20
|
US$107,581
|
|
|
2022-03-10 |
2022-03-08 |
PlS
Planned sale
|
Pres&Co-Head Bausch&Lomb/Int'l
Officer
|
3,889
-4.0%
21.76
US$84,625
|
3,889
-4.0%
|
21.76
|
US$84,625
|
|
|
2022-03-04 |
2022-03-02 |
PlS
Planned sale
|
Pres&Co-Head Bausch&Lomb/Int'l
Officer
|
11,077
-9.9%
23.37
US$258,869
|
11,077
-9.9%
|
23.37
|
US$258,869
|
|
|
2022-03-04 |
2022-03-02 |
PlS
Planned sale
|
U.S. President-Pharma Business
Officer
|
1,595
-2.4%
23.37
US$37,275
|
1,595
-2.4%
|
23.37
|
US$37,275
|
|
|
2022-03-02 |
2022-03-01 |
PlS
Planned sale
|
Pres&Co-Head Bausch&Lomb/Int'l
Officer
|
6,338
-5.3%
23.82
US$150,971
|
6,338
-5.3%
|
23.82
|
US$150,971
|
|
|
2022-02-17 |
2022-02-15 |
PlS
Planned sale
|
U.S. President-Pharma Business
Officer
|
3,251
-5.1%
25.02
US$81,340
|
3,251
-5.1%
|
25.02
|
US$81,340
|
|
|
2022-01-20 |
2022-01-18 |
PlS
Planned sale
|
U.S. President-Pharma Business
Officer
|
3,251
-4.9%
26.63
US$86,574
|
3,251
-4.9%
|
26.63
|
US$86,574
|
|
|
2021-12-02 |
2021-11-30 |
B
Purchase
|
Non-Executive Director
|
10,000
+inf%
24.17
US$241,699
|
10,000
+inf%
|
24.17
|
US$241,699
|
|
|
2021-12-02 |
2021-11-30 |
B
Purchase
|
Non-Executive Director
|
50,000
+463.8%
24.24
US$1,211,825
|
50,000
+463.8%
|
24.24
|
US$1,211,825
|
|
|
2021-06-15 |
2021-06-11 |
S
Sale
|
EVP & Chief Financial Officer
Officer
|
17,000
-12.7%
31.68
US$538,586
|
17,000
-12.7%
|
31.68
|
US$538,586
|
|
|
2020-12-08 |
2020-12-04 |
S
Sale
|
President, Ortho-Dermatologics
Officer
|
114,055
-32.7%
19.87
US$2,266,398
|
114,055
-32.7%
|
19.87
|
US$2,266,398
|
|
|
2020-11-30 |
2020-11-27 |
S
Sale
|
President, Ortho-Dermatologics
Officer
|
13,663
-5.5%
19.63
US$268,207
|
13,663
-5.5%
|
19.63
|
US$268,207
|
|
